Rhone Poulenc net up 34% - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Rhone Poulenc net up 34%

Oct 31, 2000

Rhone Poulenc has declared impressive results with a 34% growth in net profit on the back of a 14.4% rise in the sales. The operating margins have increased by almost 300 basis points in the current quarter vis–a–vis the corresponding quarter of the last year.

(Rs m)2QFQ002QFY01Change
Sales 609 697 14.4%
Other Income 20 27 35.9%
Expenditure 520 575 10.5%
Operating Profit (EBDIT) 89 122  
Operating Profit Margin (%)14.6%17.5% 
Interest 2 0 -93.3%
Depreciation 7 6 -5.9%
Profit before Tax 100 142 41.9%
Other Adjustments   
Tax 33 52  
Profit after Tax/(Loss) 67 90 34.2%
Net profit margin (%)11.1%13.0% 
Earnings per share*59.8280.27 
(annualised)   

The stock quotes at Rs 722 which implies an earnings multiple of less than 10 times FY01 annualised earnings.

Equitymaster requests your view! Post a comment on "Rhone Poulenc net up 34% ". Click here!

  

More Views on News

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK RHONE-POULENC

  • Track your investment in RHONE-POULENC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MARKET STATS